7%
savings versus the previous contracted price
11
new suppliers onboarded and trained for the auction
$63.4B
revenue company
Client
A Swiss multinational healthcare company and pioneer in prescription drugs for cardiovascular, infectious, autoimmune, and respiratory diseases. Annual revenue of $63.4 billion.
Requirement: source biospecimens with FFPE block at prices below $15,000 and build a more competitive supplier base.
Background
Formalin Fixed Paraffin Embedded (FFPE) tissue specimens preserve biopsy samples for medical and research use. Quality varies by laboratory, protocols, and data annotation, which makes reliable sourcing difficult.
Proacure's approach
With Proacure, 11 new suppliers were discovered and added to the bid and filled data gaps.
Challenges addressed
- Supplier discovery and onboarding: client supplier records had inconsistencies.
- Product specification and quality control: required FFPE blocks were not widely in stock among existing platform suppliers. Additional suppliers were onboarded with capacity to meet the specification.
- Quality requirements: licensed pathologists, protocols, and capable laboratories are required for research and drug development outcomes.
Outcome
Eleven additional new suppliers were onboarded and accepted the invitation to cover 100% of the lot. The selected bid delivered 7% savings from the previous contracted price.